OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
August 07, 2020
Budget battle threatens efforts to bolster Europe’s pharma strategy.
August 02, 2020
Andrew Hood and Cliodhna McDonough look at the key issues necessary to support business and the community in developing a long-term and sustainable response to the challenges highlighted by COVID-19.
July 09, 2020
Pandemic sparks call for European manufacturing renaissance.
June 11, 2020
Industry prospects at mercy of public discourse, policy shifts.
May 10, 2020
Pandemic fallout could spell fundamental business and policy shifts.
March 11, 2020
Medical devices manufacturers and pharma companies alike should review their compliance strategies as the EU Medical Device Regulation Date of Application approaches.
March 09, 2020
The collection of source plasma for new therapies igniting debate.
March 02, 2020
The Medicines and Medical Devices Bill was recently introduced to the UK House of Commons. Does it provide the confidence that the UK is still a leading country for life sciences? Cliodhna McDonough reports.
February 09, 2020
New OECD study doesn’t shed much light on the effectiveness of managed entry agreements for drug access.
January 14, 2020
Goals for IDMP in Europe must not be diluted in 2020, if standardized medicinal product data is to be of tangible real-world benefit, says Remco Munnik.